Journal Thoracic Oncology

Abstracts Journal of Thoracic Oncology • Volume 12 Issue S1 January 2017
FIRST NAME
LAST NAME
NATURE OF RELEVANT
FINANCIAL RELATIONSHIP
Xiaoming Cui Full-time/part-time Employee Novartis
Xiaoming Cui Stock Shareholder (directly purchased) Novartis
Kenneth Culver Full-time/part-time Employee Novartis
Craig Cummings Full-time/part-time Employee Genentech
Craig Cummings Stock Shareholder (directly purchased) Roche
NAME OF COMPANY(S)
David Currow Consultant Mayne Pharma, Specialist Therapeutics Australia Pty.Ltd.
David Currow Other (explain): Intellectual Property Mayne Pharma
Akos Czibere Full-time/part-time Employee Merrimack Pharmaceuticals
Anand Dalal Full-time/part-time Employee Novartis
Rita Dalal Full-time/part-time Employee Eli Lilly and Company
Rita Dalal Stock Shareholder (directly purchased) Eli Lilly and Company
Mercedes Liliana Dalurzo Other (explain):
I received honoraria as speaker and consultand in advisory boards
and teaching activities related with lung cancer molecular test for
Pfizer and Novartis
Tapashi Dalvi Full-time/part-time Employee AstraZeneca
Tapashi Dalvi Stock Shareholder (directly purchased) AstraZeneca, Achillion, Gilead, Inovio, BMS, Roche, Medivation
Thomas D’Amico Consultant Scanlan International Inc.
Kathleen Danenberg Full-time/part-time Employee liquid genomics
Peter Danenberg Full-time/part-time Employee liquid genomics
Cheufou Danjouma Other (explain): Proctor; I am Proctor thoracic robotic surgery
Eric Dansin Consultant BMS, ROCHE; LILLY, NOVARTIS
Eric Dansin Grants/Research Support Roche
Eric Dansin Honoraria
from Novartis, Pfizer, Roche, Astra-Zeneca, Lilly, Boehringer-
Ingelheim
Eric Dansin Honoraria Novartis, Pfizer, Astra Zeneca, Roche
Eric Dansin Other (explain):
Rahul Das Consultant Quantum Si
Mads Daugaard Other (explain):
Melinda Daumont Full-time/part-time Employee Bristol-Myers Squibb
Melinda Daumont Full-time/part-time Employee Bristol-Myers Squibb
Anthony Davies Stock Shareholder (directly purchased) Biocroi Ltd.
Advisory board or board of directors: Bristol Myers Squibb, Roche,
Lilly, Novartis
I am founder, shareholder, and chairman of the board of directors
in VAR2 Pharmaceuticals, which is the commercialization vehicle
for rVAR2-based therapeutics and diagnostics.
Marianne Davies Speakers Bureau Genentech, Merck, BMS, Astra Zenica
Farshid Dayyani Full-time/part-time Employee Roche Diagnostics
Farshid Dayyani Speakers Bureau Genentech
Filippo De Braud Consultant Merck Serono, Eli Lilly, GSK, MSD, Novartis, BMS, Servier
Gilberto De Castro Jr Consultant Novartis, Roche, MSD
Gilberto De Castro Jr Honoraria MSD
Gilberto De Castro Jr Other (explain): Advisory: Novartis
Gilberto De Castro Jr Speakers Bureau AstraZeneca, MSD, BMS
Harry de Koning Grants/Research Support
Gilberto De Lima Lopes Honoraria
Ramon Andrade De Mello Consultant Pfizer
Ramon Andrade De Mello Consultant Zodiac
Ramon Andrade De Mello Speakers Bureau Astrazeneca
Ramon Andrade De Mello Speakers Bureau Novartis
Cisio De Oliveira Brandao Full-time/part-time Employee Amgen Inc.
Cisio De Oliveira Brandao Stock Shareholder (directly purchased) Amgen Inc.
The NELSON trial is supported by: ‘Zorg Onderzoek Nederland-
Medische Wetenschappen’(ZonMw), ‘KWF Kankerbestrijding’,
‘Stichting Centraal Fonds Reserves van Voormalig Vrijwillige
Ziekenfondsverzekeringen’ (RVVZ)
Sanofi Aventis, Lilly, Pfizer, Roche, BMS, MSD, Merck-Serono,
Boehringer Ingelheim, Astra Zeneca
Copyright © 2016 by the International Association for the Study of Lung Cancer
S819